LSE company dividends information has been updated. You can find this is in the menu on any Quote page. ADVFN team.
The current 0KCC market cap is 302.48M. The company's latest EPS is 0 and P/E is -0.35.
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 5.23M | 7.73M | 31.98M |
| Operating Income | -15.2M | -22.52M | -31.26M | -74.48M | -18M |
| Net Income | -15.75M | -22.43M | -29.93M | -64.1M | -73.42M |
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 9.52M | 39.86M | 55.42M | 159.56M | 100.09M |
| Total Liabilities | 6.1M | 9.02M | 21.94M | 94.35M | 60.5M |
| Total Equity | 3.42M | 30.84M | 33.48M | 65.22M | 34.29M |
| Year End 31 December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.65M | -19.72M | -25.98M | -35.94M | -45.57M |
| Investing | -31k | -12.42M | -11.75M | -13.96M | -4.34M |
| Financing | 12.11M | 47.87M | 22.8M | 78.75M | 35.81M |
| Market Cap | 302.48M |
| Price to Earnings Ratio | -0.35 |
| Price to Sales Ratio | 0.79 |
| Price to Cash Ratio | 1.26 |
| Price to Book Ratio | 0.64 |
| Dividend Yield | - |
| Shares Outstanding | 118.62M |
| Average Volume (1 week) | 34 |
| Average Volume (1 Month) | 545 |
| 52 Week Change | 0.0% |
| 52 Week High | 2.55 |
| 52 Week Low | 2.55 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Oncocyte Corp |
| Address |
15 cushing irvine, california 92618 |
| Website | https://www.oncocyte.com |
| Industry | in vitro,in vivo diagnostics (2835) |
| Your Recent History | |||||||
Register now to watch these stocks streaming on the ADVFN Monitor.
Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use. Log in to ADVFN
Register Now | |||||||
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
| V: D: 20230601 22:48:06 |
